Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMHZCLV)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
185517-74-2; (S)-N-(2-Propynyl)-2,3-dihydroinden-1-amine; TVP1022; N-PROPARGYL-1(S)-AMINOINDAN; (S)-Rasagiline; J-500397; S-PAI; AC1NRD1Z; N-propargyl-1-(s)aminoindan; SCHEMBL332967; CHEMBL1235738; BDBM11000; (S)-N-2-propynyl-1-indanamine; RUOKEQAAGRXIBM-LBPRGKRZSA-N; MolPort-006-666-243; KS-00000LL3; ZINC19875505; ANW-23242; FCH907116; AKOS024256741; TV-1022; DB03894; AJ-75608; AS-32581; HY-14200; CJ-16483; AC-14138; TVP1022, > TC-111987; AB0052190; FT-0694134; FT-0674331; V3968; (1S)-N-methyl-N-prop-2-ynyl-indan-1-amine
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||